Hmpl 013 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FDA has granted priority review to the new drug application seeking the approval of fruquintinib for use in the treatment of adult patients with previously treated metastatic colorectal cancer.

United statesColorectal cancerMetastatic colorectal cancerPriority reviewPrescription drug user fee actFresco 2 trialFresco trialNew drug applicationHmpl 013